Their data demonstrated that ACSL5 deacetylation by SIRT6 can protect against lipotoxicity and maintain FFA metabolism homeostasis in an NAFLD model by enhancing FAO. Here, SIRT6 is linked to metabolic dysfunction-associated steatotic liver disease.